New Trade for November 10th, 2020

Futures slumped overnight after yesterday’s Dow rally and are mixed this morning.  The vaccine data induced rotation out of stay at home tech stocks is looking to continue.  Dow futures climbed higher early this morning and are pointing to more gains at the open while Nasdaq futures show a continuation of yesterday’s losses.   

The vaccine timeline is coming together quickly.  It will inevitably be the Biden administration that implements the deployment of the vaccine once it’s ready.  Thankfully, President-Elect Joe Biden seems to be serious about getting the pandemic under control.

The plan would require administering potentially hundreds of millions of vaccines in the United States alone — and billions globally.  Which means a huge bump in production for the equipment needed to make that happen.  


What’s more, those who receive the vaccine could require multiple doses.  It seems that immunity to COVID-19 following infection and recovery can last as little as three or four months.  This suggests that for the vaccine to be effective, it will require regular boosters.  That’s going to be a lot of syringes, and Becton Dickinson (BDX) and its peers will deliver them.    

Becton Dickinson holds the largest market share in the $3 billion Syringe & Injection Needle Manufacturing industry in the U.S. and is likely to increase production to meet the enormous spike in demand.  

With a long standing reputation for quality and service BDX stock is one of the top ways to play vaccine deployment. Plus, Becton Dickinson is a dividend aristocrat.